Metandienon

When ATH:
A14AA03

Characteristic.

White or white with a yellow tinge crystalline powder. Very slightly soluble in water. The easily soluble in alcohol.

Pharmacological action.
Anabolic, hematopoietic.

Application.

Disorders of protein metabolism, kaxeksija, state after a serious illness, anemia, angioedema, dysplasia, Syndrome Ternera.

Contraindications.

Hypersensitivity, mastoncus, renal failure, heart failure, myocardial infarction, CHD, diabetes, prostate adenoma, hypercalcemia.

Restrictions apply.

Pregnancy, lactation, advanced age.

Side effects.

Dyspepsia: nausea, vomiting, diarrhea, stomach ache; gepatocellûlârnaâ cancer, obstructive jaundice, hypocoagulation state with a tendency to bleeding, depression, sleep disturbance, muscle cramps, adenoma and adenocarcinoma of the prostate, seal breast, gynecomastia in men and in women virilization symptoms, polyuria, and frequent urination, swelling, leukemia, allergic reactions.

Cooperation.

It enhances the effect of anticoagulants, antiplatelet agents and hypoglycemic agents, as well as the side effects of hepatotoxic drugs.

Dosing and Administration.

Inside, before eating. Adults-on 5 mg 1-2 times a day. The highest dose is 50 mg / day. Babies: to 2 years-0.05-0.1 mg/kg; from 2 to 5 years is 1-2 mg, from 6 to 14 years is 3-5 mg in 1-2 reception. The course is to 4 Sun. Refresh course — over 6-8 weeks.